List of drugs in development for neurodegenerative diseases. Update June 2006.
Kwon
Myoung-Ok
MO
Corporate Research, Novartis International AG, Basel, Switzerland.
Herrling
Paul
P
D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy*; D018696:Neuroprotective Agents / Q000627:therapeutic use*
D018696:Neuroprotective Agents